Michael Lichtenauer
Impact in
-
- Cardiac Valve Diseases and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Genetics top 5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Papers in
-
- Cardiac Valve Diseases and Treatments 18
- Cardiac pacing and defibrillation studies 11
- Cardiovascular Function and Risk Factors 8
- Cardiac Fibrosis and Remodeling 8
- Viral Infections and Immunology Research 8
- Immunology 17
- IL-33, ST2, and ILC Pathways 10
- Co-authors
- Christian Jung (60 shared papers)Uta Charlotte Hoppe (70 shared papers)Bernhard Wernly (62 shared papers)Hendrik Jan Ankersmit (20 shared papers)Marcus Franz (31 shared papers)Konrad Höetzenecker (16 shared papers)Paul Christian Schulze (21 shared papers)Alexander Lauten (21 shared papers)
In The Last Decade
Michael Lichtenauer
157 papers receiving 3.2k citations
Michael Lichtenauer's Hit Papers
Peers
Comparison fields: 5 of 127
- Cardiology and Cardiovascular Medicine 1.0k
- Genetics 251
- Immunology 366
- Internal Medicine 47
- Nephrology 91
Countries citing papers authored by Michael Lichtenauer
This map shows the geographic impact of Michael Lichtenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lichtenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lichtenauer more than expected).
Fields of papers citing papers by Michael Lichtenauer
This network shows the impact of papers produced by Michael Lichtenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lichtenauer. The network helps show where Michael Lichtenauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Lichtenauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Hit paper breakdown → | 2022 | 245 |
| 2 | 2010 | 121 | |
| 3 | 2018 | 110 | |
| 4 | 2018 | 103 | |
| 5 | 2017 | 92 | |
| 6 | 2011 | 86 | |
| 7 | Elevated HSP27, HSP70 and HSP90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. | 2009 | 85 |
| 8 | 2011 | 67 | |
| 9 | 2020 | 66 | |
| 10 | 2021 | 62 | |
| 11 | 2017 | 62 | |
| 12 | 2009 | 62 | |
| 13 | 2016 | 61 | |
| 14 | 2017 | 56 | |
| 15 | 2009 | 55 | |
| 16 | 2009 | 53 | |
| 17 | 2019 | 52 | |
| 18 | 2019 | 49 | |
| 19 | 2019 | 48 | |
| 20 | 2019 | 46 |
About Michael Lichtenauer
Michael Lichtenauer is a scholar working on Cardiology and Cardiovascular Medicine, Immunology, Surgery, Physiology and Nephrology, having authored 161 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (18 papers), Cardiac pacing and defibrillation studies (11 papers), IL-33, ST2, and ILC Pathways (10 papers), Cardiovascular Function and Risk Factors (8 papers), Cardiac Fibrosis and Remodeling (8 papers), Viral Infections and Immunology Research (8 papers), Hemodynamic Monitoring and Therapy (6 papers) and Long-Term Effects of COVID-19 (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.0k citations), Genetics (251 citations), Immunology (366 citations), Internal Medicine (47 citations) and Nephrology (91 citations). Michael Lichtenauer has collaborated with scholars based in Austria, Germany and Sweden. Frequent co-authors include Christian Jung, Uta Charlotte Hoppe, Bernhard Wernly, Hendrik Jan Ankersmit, Marcus Franz, Konrad Höetzenecker, Paul Christian Schulze, Alexander Lauten, Vera Paar and Malte Kelm. Their work appears in journals such as European Journal of Clinical Investigation, Clinical Research in Cardiology, European Heart Journal, International Journal of Molecular Sciences and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.